Health technology assessment (HTA) agency NICE has published final draft guidance for IL-23 inhibitor Omvoh (mirikizumab), ...

The Immune Cell Engager Partnering & Investment Summit is here. As part of the game-changing Partnering & Investment Series, ...

Back for its second year, the ADC Partnering & Investment Summit unites 100+ top ADC companies, pharma leaders, and investors ...

Returning for its second year, the Autoimmunity & Inflammation Partnering & Investment Summit unites over 80 on-scope and ...

Respondents broadly supported clearer guidance on how evidence on health inequalities should be presented and how impacts are ...

For well over a decade, scientists, health leaders, and global organisations have sounded the alarm on antimicrobial ...

Connecting 80+ EHS experts in pharma and biopharma on the West coast, this year's meeting will address the challenges of ...

Despite a certain amount of upheaval at the FDA, the agency has continued to keep up with its scheduled approvals and ...

Eli Lilly has won a green light from the FDA for new dosing for its Alzheimer's disease therapy Kisunla, which carries a ...

The deal for CARGO, which remains relatively well funded despite its troubles, comes with a contingent value right (CVR) that ...

The acquisition – which will see MSD pay $107 for each American Depository Share (ADS) in UK-headquartered Verona – is the ...

The high dose of Wegovy is one part of Novo Nordisk's plan to defend its obesity business, along with a major ...